Page last updated: 2024-11-02

pirenzepine and Embolism, Pulmonary

pirenzepine has been researched along with Embolism, Pulmonary in 2 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hägg, S1
Tätting, P1
Spigset, O1
Waage, IM1
Gedde-Dahl, A1

Other Studies

2 other studies available for pirenzepine and Embolism, Pulmonary

ArticleYear
Olanzapine and venous thromboembolism.
    International clinical psychopharmacology, 2003, Volume: 18, Issue:5

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Pi

2003
Pulmonary embolism possibly associated with olanzapine treatment.
    BMJ (Clinical research ed.), 2003, Dec-13, Volume: 327, Issue:7428

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Humans; Male; Olanzapine; Pirenzepine; Psychotic Disor

2003